The mechanisms are not simply additive but interact in complex ways that amplify overall effects
GLP-1 receptor agonists are FDA-approved for type 2 diabetes and obesity, not autoimmune conditions
This decision should always be guided by clinical evaluation via a doctor consultation, not guesswork
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context around how your body processes GLP-1 and GIPR signaling
Many women have reported missed periods, irregular bleeding, spotting, lighter periods, heavier bleeding, or changes in cycle timing while taking tirzepatide
In: ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials